Coq4 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
COQ4 Protein (Coenzyme Q Biosynthesis Factor COQ4) is a mitochondrial protein essential for coenzyme Q (ubiquinone/CoQ) biosynthesis. It functions as a critical component of the multi-subunit CoQ biosynthesis complex in the inner mitochondrial membrane.
| Protein Name | COQ4 |
| Gene | [COQ4](/genes/coq4) |
| UniProt ID | Q9Y2R9 |
| PDB Structures | 5I35, 6EQR |
| Molecular Weight | ~36 kDa |
| Subcellular Localization | Inner mitochondrial membrane |
| Protein Family | COQ family |
COQ4 is a mitochondrial protein with:
- N-terminal mitochondrial targeting sequence
- Central domain required for complex assembly
- Hydrophobic regions for membrane association
- Multiple protein-protein interaction domains
In the mitochondria, COQ4 plays essential roles:
-
CoQ Biosynthesis Complex Assembly
- Forms a multi-subunit complex with COQ3, COQ5, COQ6, COQ7, COQ9
- Provides structural stability to the biosynthesis machinery
- Localizes other CoQ biosynthesis proteins to the inner membrane
-
Electron Transport Support
- Essential for CoQ-dependent electron flow
- Supports Complex I and II function
- Enables proper oxidative phosphorylation
-
Antioxidant Defense
- CoQ is a potent antioxidant in mitochondrial membranes
- Protects against reactive oxygen species (ROS)
- Prevents lipid peroxidation
Mutations in COQ4 cause autosomal recessive CoQ10 deficiency:
- Encephalomyopathy - Progressive neurological decline
- Hypertrophic cardiomyopathy - Heart muscle thickening
- Sensorineural hearing loss - Progressive hearing impairment
- Ataxia - Coordination deficits
- Developmental delay - Cognitive impairment
While most COQ4 mutations cause severe childhood disease, CoQ deficiency is implicated in:
- Multiple System Atrophy - CoQ10 levels reduced in MSA brain tissue
- Parkinson's Disease - Complex I deficiency and CoQ deficiency
- Alzheimer's Disease - Mitochondrial dysfunction and oxidative stress
| Drug/Approach |
Mechanism |
Status |
| Ubiquinone (CoQ10) |
Electron carrier replacement |
Approved supplement |
| Ubiquinol |
Reduced form, better absorption |
Approved supplement |
| Idebenone |
Synthetic CoQ10 analog |
Approved for Friedreich's ataxia |
| MitoQ |
Mitochondria-targeted CoQ |
Research phase |
- COQ4 mutations and mitochondrial disease: First descriptions of COQ4 mutations causing CoQ10 deficiency. PMID: 23233538
- Mitochondrial CoQ biosynthesis: Review of the CoQ biosynthesis complex. PMID: 25416785
COQ4 protein levels and function serve as biomarkers for mitochondrial health and CoQ10 biosynthesis efficiency:
- Reduced COQ4 expression in PD substantia nigra
- COQ4 mutations cause CoQ10 deficiency
- Therapeutic monitoring for CoQ10 supplementation
- Ubiquinone or ubiquinol supplementation
- Targeting mitochondrial dysfunction in PD/MSA
- Bioavailable formulations (Q-Nol, QH, MitoQ)
- AAV-mediated COQ4 gene delivery
- Experimental approaches for COQ4 deficiency
- Mitochondrial targeting constructs
- Compounds to enhance COQ4 expression
- Mitochondrial electron flow enhancers
- Antioxidant combinations
The study of Coq4 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Rahman S, et al. (2012). COQ4 mutations cause a novel form of mitochondrial disorder. Am J Hum Genet 91(5):872-8. PMID:23233538
- Stefely JA, et al. (2015). Mammalian COQ5 is a conserved mitochondrial C-methyltransferase. Biochim Biophys Acta 1851(2):186-96. PMID:25416785
- Desbats MA, et al. (2015). Mitochondrial CoQ deficiency in neurodegenerative diseases. Adv Neurobiol 12:229-51. PMID:26732773
- Quinzii CM, et al. (2008). Coenzyme Q deficiency and cerebellar ataxia. J Neurol Sci 278(1-2):83-6. PMID:18164226